These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28606106)

  • 21. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.
    O'Brien KL; Wolfson LJ; Watt JP; Henkle E; Deloria-Knoll M; McCall N; Lee E; Mulholland K; Levine OS; Cherian T;
    Lancet; 2009 Sep; 374(9693):893-902. PubMed ID: 19748398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How many episodes of hospital care might be prevented by widespread uptake of pneumococcal conjugate vaccine?
    McIntosh ED
    Arch Dis Child; 2003 Oct; 88(10):859-61. PubMed ID: 14500302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive disease and hospital-treated pneumonia among people aged ≥65 years: a retrospective case-control study.
    Leventer-Roberts M; Feldman BS; Brufman I; Cohen-Stavi CJ; Hoshen M; Balicer RD
    Clin Infect Dis; 2015 May; 60(10):1472-80. PubMed ID: 25669354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential serotype coverage of three pneumococcal conjugate vaccines against invasive pneumococcal infection in Italian children.
    Azzari C; Moriondo M; Cortimiglia M; Valleriani C; Canessa C; Indolfi G; Ricci S; Nieddu F; de Martino M; Resti M;
    Vaccine; 2012 Mar; 30(16):2701-5. PubMed ID: 22178097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pneumococcal infections. New vaccine protects even young children].
    Meissner T
    MMW Fortschr Med; 2001 Jul; 143(28-29):17. PubMed ID: 11499141
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical manifestations of invasive pneumococcal disease by vaccine and non-vaccine types.
    Browall S; Backhaus E; Naucler P; Galanis I; Sjöström K; Karlsson D; Berg S; Luthander J; Eriksson M; Spindler C; Ejdebäck M; Trollfors B; Darenberg J; Kalin M; Örtqvist A; Andersson R; Henriques-Normark B
    Eur Respir J; 2014 Dec; 44(6):1646-57. PubMed ID: 25323223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Medical indications and effectiveness of the pneumococcal conjugate vaccine].
    Reinert RR
    Laryngorhinootologie; 2006 Apr; 85(4):291-8; quiz 299-300. PubMed ID: 16615030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical burden of pneumonia, meningitis and septicemia in Norway 2 years after 7-valent pneumococcal conjugate vaccine introduction.
    Munson S; Raluy-Callado M; Lambrelli D; Wasiak R; Eriksson D; Gray S
    Scand J Public Health; 2015 Aug; 43(6):657-66. PubMed ID: 25979727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential benefits from currently available three pneumococcal vaccines for children--population-based evaluation.
    Rückinger S; van der Linden M; Siedler A; von Kries R
    Klin Padiatr; 2011 Mar; 223(2):61-4. PubMed ID: 21271500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative incidence dynamics and serotypes of meningitis, bacteremic pneumonia and other-IPD in young children in the PCV era: Insights from Israeli surveillance studies.
    Ben-Shimol S; Givon-Lavi N; Grisaru-Soen G; Megged O; Greenberg D; Dagan R;
    Vaccine; 2018 Aug; 36(36):5477-5484. PubMed ID: 28579230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of 13-Valent Pneumococcal Conjugate Vaccine on Meningitis and Pneumonia Hospitalizations in Children aged <5 Years in Senegal, 2010-2016.
    Faye PM; Sonko MA; Diop A; Thiongane A; Ba ID; Spiller M; Ndiaye O; Dieye B; Mwenda JM; Sow AI; Diop B; Diallo A; Farrar JL
    Clin Infect Dis; 2019 Sep; 69(Suppl 2):S66-S71. PubMed ID: 31505625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated with non-uptake of measles-rubella vaccine second dose among children under five years in Mtwara district council, Tanzania, 2017.
    Magodi R; Mmbaga EJ; Massaga J; Lyimo D; Mphuru A; Abade A
    Pan Afr Med J; 2019; 33():67. PubMed ID: 31448029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adult immunizations: are they worth the trouble?
    LaForce FM
    J Gen Intern Med; 1990; 5(5 Suppl):S57-61. PubMed ID: 2231067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic and clinical evaluation of a catch-up dose of 13-valent pneumococcal conjugate vaccine in children already immunized with three doses of the 7-valent vaccine in Italy.
    Boccalini S; Azzari C; Resti M; Valleriani C; Cortimiglia M; Tiscione E; Bechini A; Bonanni P
    Vaccine; 2011 Nov; 29(51):9521-8. PubMed ID: 22008820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in Germany.
    Imöhl M; Möller J; Reinert RR; Perniciaro S; van der Linden M; Aktas O
    BMC Infect Dis; 2015 Feb; 15():61. PubMed ID: 25885764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pneumococcal vaccination; arguments for informing parents about the options available].
    Beaujean DJ; Verweij MF; van Steenbergen JE
    Ned Tijdschr Geneeskd; 2005 Apr; 149(17):909-11. PubMed ID: 15884402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical burden of multi-cause and pneumococcal pneumonia, meningitis, and septicemia in Hungary. Results of a retrospective study (2006-2011)].
    Ludwig E; Jorgensen L; Gray S; Munson S; Chou K; Gutterman EM
    Orv Hetil; 2014 Sep; 155(36):1426-36. PubMed ID: 25176517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of willingness to pay for self-paid vaccines in China.
    Hou Z; Jie Chang ; Yue D; Fang H; Meng Q; Zhang Y
    Vaccine; 2014 Jul; 32(35):4471-4477. PubMed ID: 24968160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating the cost-effectiveness of an infant 13-valent pneumococcal conjugate vaccine national immunization program in China.
    Shen K; Wasserman M; Liu D; Yang YH; Yang J; Guzauskas GF; Wang BCM; Hilton B; Farkouh R
    PLoS One; 2018; 13(7):e0201245. PubMed ID: 30044865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine.
    Albrich WC; Baughman W; Schmotzer B; Farley MM
    Clin Infect Dis; 2007 Jun; 44(12):1569-76. PubMed ID: 17516400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.